Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quest/Unilab reveal amendments, extend offer:

This article was originally published in Clinica

Executive Summary

Teterboro, New Jersey-based Quest Diagnostics has extended its offer for Unilab of Tarzana, California, until February 3 to allow it to circulate amendments to Unilab's shareholders. The merger agreement was most recently extended to January 31. The changes to the deal - necessitated by antitrust issues raised by the US Federal Trade Commission - will result in a reduction in the price paid by Quest.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060773

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel